Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TKS,
I really wouldn't worry about it. If it happens .... within 30 days .... it happens .... if not ..... it is the SoS. Volume and price tells the tale.
No worries either. Pied Piper sez ..... ECSL about to have an "alpine" move. Of course ya gotta know when ta hold'em ... know when to fold'em for those who know that story.
Amigo Mike
LOL Weasel,
Some been picking up ZIVOW lately.
22000 purchase at avg price ~.39 during lunch and 2500 still bid at .35.
Interesting in my book ..... someone been buying them over the past week+. Roughly 22000 last week too .... wonder if that was a flip trade as a some of that happened in the .24 range.
Amigo Mike
C'mon TKS,
We just went through 3 1/2 years of shareholder updates that never hit any timeline offered by ECSL. Ya think they will provide news in the next 30 days from last update ? Maybe .... and would be a first.
THEY AREN'T IN CONTROL. THEY GET TO MOVE FORWARD WHEN OTHERS DECIDE COME TO THE TABLE TO MAKE IT HAPPEN. (which I have stated for years).
You should read the last update carefully too about the JV.
Amigo Mike
TKS,
Mills still running this company like it is a private company. Lack of disclosures. When Mills needs something he calls his people that have been providing money all these years. Doesn't inform everyone. Obvious the ownership is concentrated among few shareholders. A real shareholders meeting cost money to solicit votes ... that ECSL doesn't have. And ya think Mills is gonna stand up in front of investors and do shareholders address and take questions ? LOL. I still have that bridge for sale.
Just look at the disclosures same people over and over and some post here. Of course there should be company records detailing such a vote and as a shareholder you have the right to inspect corporate records. Wouldn't it be fun to know who participated in the voting ? =)
Funny, public mention of new ECSL ticker ..... now erased from the public domain. LOL. Of course once its posted on the internet it never really disappears.
What have they been doing the last 6 months ??? Waiting on others to make it happen. It is written all throughout the Lawrence update. I'm sure ECSL is ready to do something .... but ... it's everyone else.
And you don't know what the Mabanaft deal looks like until it is announced (IF it is announced) and its pretty much a guarantee that we won't see all the details. Signing a JV with Mabanaft ..... you are jumping to a conclusion with no facts ..... i.e. ECSL worldwide overnight. Yes .... a definitive deal with Mabanaft should definitely be a big deal for ECSL. But until details are available .... guessing is futile.
Amigo Mike
TKS,
Mods are an Ihub thing ..... they have nothing to do with the company or informing anyone of any thing associated with the topic of the board. They are moderating conversation for Ihub and ... themselves in some cases ..... and should never be considered representative of the company or a steward of company information in any way.
Those claiming DD here ....as has always been the case ..... are "direct dial" to ECSL and / or spouting drivel from ECSL IR that is totally worthless. And if it isn't direct dial, they know someone else claiming knowledge. ECSL IR is a black hole and total waste of shares. Just a shield for Mills. There is no one here that should have any knowledge of confidential company discussions other than awareness that they are happening unless of course they are involved and have an NDA in place in which case they should say nothing at all. Difficult to DD a company that sez and does almost nothing outside of speaking directly with them.
The "direct dial" is obvious as all hell when you see the names in the ECSL filings providing money to the company. Ya think that magically happens by osmosis like Mills envisions needing money in his mind and magically those thoughts are sent to shareholders via telepathy and they receive those thoughts and send money ? And things like a "shareholders meeting". ROFLMAO. Requires contact does it not ? DUH. Funny that no one here directly mentioned a shareholders meeting and increase in authorized shares even though they knew about it before the latest "update" and discussed it elsewhere. Name change was tossed about but that is trivial relative to having a shareholder meeting and increase in authorized shares.
There is no one here looking out for you. Everyone has their own agenda. Protect yourself at all costs and believe nothing you can't verify for yourself.
And I would encourage you to read Lawrence's updates very carefully. They paint the picture for the most part on what's happening. And then when you read them historically in sequence, you can get an even better picture from which you can infer the real story.
Like I said I still take Lawrence at his word. IMO, ECSL is still trying to land deals to support the future of the company. But what that all looks like remains to be seen and is yet to be "definitive" in any way. What is definitive is ECSL has title to the Lorton properties but has failed to make balloon payment to Lorton that was due end of June. There has been no public filing of an extension to that date or an adjustment to the agreement.
Amigo Mike
TKS,
Solution ..... IHUB offers features to support filtering out the worthless drivel and improve your experience on the platform. Easy to use.
There are numerous candidates in ECSLland as much as it pains me to say that.
Amigo Mike
Weazel,
💯💯💯💯💯
Same shit .... different year. Common sense is to bring in industry people to help facilitate the business. But we know that doesn't apply to ZIVO.
Amigo Mike
Welp,
Yaldoo officially appointed as Director of ZIVO today.
Another in long line of headscratching moves by ZIVO ....... IMO.
HOW ABOUT A RECENTLY RETIRE ANIMAL PHARMA EXECUTIVE OR VENTURE GUY IN THE NATURAL INGREDIENTS OR NEUTRACEUTICAL SPACE. GEEZUS.
I realize that he's probably done more monetarily for ZIVO than anyone but ..... just read the resume .... brings nothing to the table in any business ZIVO might hope to be in ...... AND .... his initially getting involved with ZIVO had contingency of Dahl being CEO who was kept around probaly 6-8 years longer than he should have been. Yaldoo's had a seat in the boardroom all these years so wired into what's happening.
But IMO, just doesn't make any sense to me.
Amigo Mike
Someone been nibbling at ZIVOW of late.
Interesting .... dunno if meaningful or not but haven't been expecting to see much action on that given the exercise price is $33 now. Of course a deal with global animal pharma could run those sharply upward and offer high leverage ...... assuming stock price launches. Cheap option really with just under 2 years remaining on it.
ZIVO the stock ..... frankly surprised it has not bled. It's basically flat for a couple months now hanging around $8 save the occasional drop/rise due to wide spreads. As we've discussed there's basically little to no float on this.
Currently a bidder for 2600 shares at $7.60 which is more volume than what's been trading for entire days of late. That area seems to be getting solid support still.
I'm still sitting tight on swing.
I want to see update on algae production.
I want to see update or any indication whether there is more than 1 global animal pharma involved with the coccidiosis candidate.
I want to see indication of MONEY needs as I'm sure that cash is running low again. Ideally animal pharma getting involved would like to see part of deal include purchase of shares from ZIVO for funding .... and OWNERSHIP ...... meaning fully invested in the process AND door open to acquisition.
I would also like to see some other tests done with the algae as an ingredient against cholesterol, sports recovery, etc ...... Simple shit ... not a ton of money. They have GRAS designation ..... no excuses to be able to make some claims on some easy stuff.
Amigo Mike
LOL TKS,
Sleepwalking is an understatement.
It is laughable that a company name and ticker change hasn't happened already. Rumor that has been posted publicly is it's CBFL. I can think of other tickers that would be more appropriate to describe this company. But that is fun for another time.
But volume sez it all. Obvious that longs aren't buying in the open market. New investors aren't buying it. Today 114 shares traded so far ? Doesn't portend investor confidence. But the other side .... no significant selling.
No news this week according to pied piper ...... and continues touting stock price purchases that haven't existed for a decade+ and really has no value to anyone. Laughable commentary and nothing about ECSL. But you can do your ECSL DD based on posting of other company's news ..... ROFLMAO. The power of positive thinking will surely make it happen for ECSL but no real surprise they haven't come out firing news out there left and right.
Personally still in the camp that ECSL has deals working but remains to be seen what that looks like for the company and us shareholders. Of course ANY deal is a positive given the history here (making history LOL). Uplisting mentioned again. LOL ..... we've been over that previously. And additionally tough for a company that still isn't even registered with the SEC which is a basic first step. What have the legal specialists been doing all this time ? Also surprised not to hear several other things but this is ECSL.
Amigo Mike
NEnorth,
He's talking about the Defense Logistics Agency and General Services Administration both of which handle sourcing and purchasing for the military and govt agencies respectively. Of course he could have just said that but ......
I wouldn't get your hopes up of ECSL having involvement there. They don't sell fuel for one. And of course this arena is dominated by the majors. And ya think ECSL will get a piece ?? LOL.
ECSL might land a major petroleum company as a client for the terminal who might supply govt installations in the area. But wouldn't count on ECSL being a "supplier" to the govt.
You need to think logically about the realities of what ECSL is until something drastically changes.
Amigo Mike
Agreed,
Cannot build a position with the spread as wide as it is and the movement either way if someone sniffs it.
Happy to see it funded by a major pharma ..... but I'd like to know if it is the same pharma as before .... or is it another pharma getting into the fray ..... and if it is another pharma ..... is there a competition brewing .... or did other pharma drop from the picture. I would think that to be a valuable piece of info.
My impression is the original pharma .... who actually botched the original test ..... was continuing to talk to ZIVO all this time. So is it still them or someone else??? Can't tell from the PR. The original pharma I would think has all the data. This test is a little different and some different variations that I think are certainly worthy of testing but at same time, the data from prior tests is what it is ... and was performed under real world 42 day grow cycle conditions.
Personally I am ALL FOR COMPETITION. I have noted here before .... if I were Payne, I would have sent data to ALL the major pharmas with coccidiosis treatments and I would have done articles or interviews with animal groups pushing to have antibiotics removed from animal therapeutics. Enough dicking around. =)
But at same time I do realize ZIVO may be in a delicate position ... but at some point, if you think you have the breakthrough that you do ...... you need to turn up the gas and try to make best deal possible to commercialize. If all the eggs are in a single pharma's basket, then they get to dictate ...... If everyone gets the data and a chance to review and decide ...... then everyone knows the deal when everything shakes out if ZIVO has da goods or not and ZIVO can choose the best option to move forward. And if the other pharmas don't step up and have their products adversely impacted ... they had their shot at it.
In my book, chickens is only the tip of the iceberg. ZIVO toss in some additional data on other potential verticals, and a major pharma could get those things done much faster. And who knows, maybe one of them would just buy the company. Like glucosamine and animal joint health is a layup. Glucosamine I don't think really does much of anything, ZIVO on the other hand ..... they could do those tests easy. And animal joint supplement blows the rest away.
So I agree, it is time for major pharma to $hit or get off the pot with this. IMO ZIVO needs to turn up the gas bigtime. And at end of this time, need an offer on the table.
Amigo Mike
Kinda interesting that you cannot buy any size in this stock without moving it sharply. Insiders holding very tightly.
Looks like someone willing to part with 2000 shares at $11.55 but other than that it is 100 share lots across the board.
And I reestablished my $99.00 GTC offers that expired .... =)
Amigo Mike
This thing should be over $10 to stay today..... IMO
It is long past due getting past $10 but with a "GLOBAL LEADER" in animal pharma footing the bill to do this confirmation test ....... while not what we were looking for ...... ZIVO is in the door with a big boy who is forking up money to get involved.
Would like to see some more news from ZIVO .... on other fronts as well.
Guess this could be reason why someone been "nibbling" at the stock. No filing from Maggiore so I guess the prior jump was not him. Good news.
Amigo Mike
Can't say this is what I was looking for .... but also can't say that I'm surprised.
Also no indication in the PR as to whether this is a new animal pharma .... "A GLOBAL LEADER" ........ or the one already involved with the prior testing. Of course anyone can look up which animal pharmas offer ionosphere based coccidiosis treatments and vaccines ....... and draw up your short list. The names everyone knows .... including one that Payne used to be CEO of animal pharma division prior to acquisition.
Interesting information
Funded by the major animal health company, the study focuses on the overall health and productivity of the birds under typical industry conditions, and compares administration of ZIVO’s product versus an ionophore-based treatment and versus an ionophore-based treatment combined with ZIVO’s product. The study also compares the benefits of ZIVO’s product combined with coccidiosis vaccine versus administration without the vaccine. Results from the study are expected to be available in September.
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08 2024 - 8:00AM
Business Wire
ZIVO Bioscience, Inc. (NASDAQ: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces the initiation of a 42-day confirmatory study targeting coccidiosis in collaboration with a major global animal health company.
This new study aims to further validate the efficacy of ZIVO’s non-antibiotic, immune-modulating product designed for the prevention and treatment of coccidiosis in broiler chickens. Building upon the positive outcomes of previous trials, this study replicates real-world conditions to ensure the product's effectiveness in commercial poultry production environments.
“We are delighted to support a global leader in animal health as they perform this confirmatory study, which holds potential to accelerate commercialization of our innovative treatment. Coccidiosis costs the poultry industry more than $10 billion annually, and traditional treatments rely heavily on antibiotics and ionophores that have not seen significant innovation in over six decades,” said John Payne, Chairman and CEO of ZIVO Bioscience.
“This 42-day study is a significant step forward in our mission to provide sustainable, antibiotic-free solutions for the poultry industry. Our product represents a groundbreaking alternative designed to boost the immune response of broiler chickens without the adverse effects associated with legacy treatments. We are optimistic the results of this study will further support its market readiness,” he added.
Funded by the major animal health company, the study focuses on the overall health and productivity of the birds under typical industry conditions, and compares administration of ZIVO’s product versus an ionophore-based treatment and versus an ionophore-based treatment combined with ZIVO’s product. The study also compares the benefits of ZIVO’s product combined with coccidiosis vaccine versus administration without the vaccine. Results from the study are expected to be available in September.
About Coccidiosis
Coccidiosis is a protozoal disease that causes diarrhea, weight loss, decreased performance and increased mortality in poultry. This disease represents a significant economic challenge for the global poultry industry, as indicated by a 2020 study that estimated annual costs ranging from $10 billion to $17 billioni. Products for treating coccidiosis are mostly antibiotic- or ionophore-based, and no significant new commercial technology has been introduced in the past 60 years. The global poultry industry spends more than $1.5 billion annually on coccidiosis control, primarily using decades-old compounds that industry and consumers alike want to replace due to the risks of developing drug resistance. Coccidiosis is a common disease for chickens, especially among young chicks, and can be fatal or result in compromised digestion.
About ZIVO Bioscience
ZIVO Bioscience is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.
Wow,
The private chatter is lit up with laughter at the latest twists and turns on this board. Absolutely hilarious !!!
From locked up know everything longs repeating what has already been spoken as a reality for years .... to back biting and in fighting. Can't make this stuff up. Still spouting nothing relevant to ECSL. And others disappointed by the update. ROFLMAO !!
Not sure what some where looking for in an "update" from mgmt. If there is no PR announcing a deal, there is no news that can be discussed. i.e. no news by last Friday means .... NO NEWS .... so if you take Lawrence at his word ...... they are "working on it" ...... which is the crux of the update ..... they can't say a damn thing more about it. One point he made rings true in this space, there is ALOT of secrecy and confidentiality surrounding the terms of deals in the petroleum space. Been that way for years. So if a deal is announced, don't expect to see details other than very high level stuff.
It does amaze me the cracker jack team at Green Path has not landed a "newsworthy" contract for the additive. Given the sales are so small, almost ANY deal is worthy of note. They been at it for more than long enough.
Lawrence said 30 days. We'll see. I'm still in the camp he has deals brewing.
Amigo Mike
My bet is on a new Maggiore buy. Guess we'll see soon. That of course would be good news / bad news if it turns out to be the case. Good news ... insider buy. Bad news ... no news soon.
So far the bid still being maintained ....
$7.81 / $9.37
I'm somewhat surprised and still don't know why retail would buy it like yesterday with the cone of silence in place.
Amigo Mike
Easy come easy go.
Wasn't me playing with the stock or selling any of the open swing position I still have.
Amigo Mike
LOL,
$11 ..... Hmmmmmm .....
5 MMs stacked at roughly $11.50ish area give or take a penny or 2.
Amigo Mike
LOL Weasel,
Funny you asked about my offers. I think I might have mentioned this before but to answer your question RE: Offer.
I actually had GTCs on all my accounts for ZIVO at $99.00. But just checked and the GTC orders expired a couple weeks ago .... so I will reestablish them. Don't want any shenanigans using my accounts even though I know it happens anyway. That's only a roughly $300 million valuation. Of course ... IMO .... with multiple verticals realized .... IMO it is worth more than that.
Amigo Mike
Personally,
I've no problem with the stock gaining $10 and .... hopefully ..... holding that new level. Double digits is a milestone.
But again wouldn't shock me if that is Maggiore buying although I would think that he can't given the EoQ at this point.
The Director and CFO awards are still bugging me. Excessive ...... unless ........
Amigo Mike
Agree,
Plus can't move any size even if you wanted too ...
I'm just waiting patiently. Have to wonder why someone is buying above recent market prices and 20% higher at $10 this morning. Of course .... IMO ... the company is much further along than it ever was before under Dahl and the price should already be well north of $10 just to get back to valuation prior to dismal 2023 fiasco ......... plus ..... we don't know where negotiations stand with animal pharma ........ so even though volume is minimal ...... gotta wonder.
Frankly wouldn't be shocked to see Form 4 in a couple days. LOL
And strange that now 2 bidders above $9 and some "offer stacking" around $11.50ish.
Amigo Mike
True,
I was trying to pick off shares in the low $5 range in past weeks but it isn't worth the time when there are so many other stocks to make bank on and ya can't buy much of anything to meaningfully trade anyway.
But someone continue to step up into upper $7 range anytime there is the slight bit of selling.
And just as I say it ..... buying above $8 and into the $9 range.
And now best offer $11.55 .... LOL
9.10x11.55
Pharma news right now would be fun to see what happens.
Amigo Mike
LOL,
No one wants to pay above $8/share for this. Would be surprise to see upward movement without news occurring .... or in anticipation of news ..... but one can't anticipate what it hears nothing about ...... =)
Amigo Mike
My bad,
I should have said raise of "authorized" share count.
Amigo Mike
Shouldn't investors be buying the stock on this update ?? LOL.
Guess not .... too busy buying from the company. Hush hush shareholder vote finally mentioned and raise of outstanding share count. Already known to most but funny not mentioned by "leadership". "Board Approval" .... LOL .... what Board? Listed board members are Ron Mills.
Amigo Mike
Weasel,
I think your assertion is true. So far the stock is generally holding around the $8 level save a couple sells here and there. Someone still buying it back to $8 .... thus far. Given the tightly held nature of the stock I think that is a good sign that Payne is still working a pharma deal. Externally no reason for an outsider to buy it. No news. No info.
So we wait on the other shoe to drop. And like you ... I'm watching for clues as to the stock movement. The way these low floaters are popping off these days ..... a pharma deal from ZIVO could send this northward big time on release. Of course I would expect ZIVO to botch or blunt the release of that info as they always do ... if it happens of course. Remember that this is a novel approach for animal pharma. No change in this space for 6 decades. So a deal as we see not happening overnight. Encouraged by recent Maggiore buy and the stock generally maintianing level .........leads me to think things are still being worked given it's timing and the action.
Amigo Mike
Oh sure,
I gotchya ........ Lotta worthless noise here ..... and virtually nothing about ECSL. Sad really.
Amigo Mike
Slojab,
Did ya notice March quarterly disclosure posted 3 different times over 3 weeks on OTC Markets ? Last one noted as being prepared by Consultant Ken Klipper.
Also share trackers and OTC Markets have changed the outstanding share count. Strangely dropped from near 103 million down to 98+ million. Roughly the difference of shares given to Lorton to close the land deal. Given June 30th is FY end for ECSL, wouldn't be shocking to see updates although strange for it to drop.
https://www.otcmarkets.com/stock/ECSL/disclosure
https://www.otcmarkets.com/stock/ECSL/security
Amigo Mike
We do ?
... hear "something" every week ? I must of missed all the ECSL news.
Strange.
Amigo Mike
Gwinner,
It appears to me that Maggiore just bought shares in the open market so I'm not sure what the minimum timeframe is for the company to then announce material news.
That said, IMO, there could be as many as 3 different material events short term. You can probably figure out 1 or 2 of them ...... I think there could be a surprise item in there too.
I am standing pat with my open swing position in lieu of no information to the contrary and have already more than covered the cost and riding free. As noted previous, I am leaning towards a sale of the company at this point but a couple different things could happen. And I still think a fair price is multiples of the current price.
Amigo Mike
It is about time these clowns got the cloud and AI business launched .... they've been discussing if for over 2 years.
I expect brighter days ahead. Need to see what the latest financing looks like both for SolunaCloud and for Dorothy 2 and SLC.
Convertible debt is likely going to be forced as today would mark the first time the company can force conversion under the latest amendment. Reducing debt but I think the market will have to absorb new shares again.
We shall see how it plays
Amigo Mike
Interesting on a Friday to see some positive action and .... above $8 with the bid above $8 as well.
Albeit we are talking pocket change volume here. Nice to see though. Too bad still ZERO from ZIVO.
Amigo Mike
The question is who gonna buy it above $8 in lieu of zero from ZIVO ? Sellers showing more size again today.
Maybe new company slogan ...... ZERO from ZIVO !!
Amigo Mike
A couple more Form 4s posted this evening for directors I believe completing the reporting on the laughable adjustments. I surely don't have any issue with directors being compensated and I know they were behind on it as explained in the filings .... but given the lack of .... frankly ... anything from this company in a while, there isn't much public justification for the awards. The Marchiando award ..... um ..... WTF. ZIVO don't need much more than a bookkeeper.
The Maggiore Form 4 shows he purchased over 3700 shares on the open market on June 12th but that many shares didn't trade so guessing he was almost all the action from June 10-12. Buying with Maggiore sometimes good .... sometimes not so good. In this case .... good news of an actual insider buy. On the flip side of that, he can't buy in front of or if in receipt of material news ...... so ... IMO, there isn't any significant news coming from ZIVO in the very short term. The cone of silence may have a purpose. The question is ... what ? I won't be buying with Maggiore here.
8K also posted. And frankly, scratching my head. Matter of fact vote results .... and that's it. No shareholder address for the annual meeting offered. No update on where the company is and where it is going.
Frankly, I am leaning heavily towards ZIVO selling to a big boy at this point. They've characterized the molecule and mechanism of action and have filed multiple patents. Last I checked I believe those patents surrounding these items were still in process. Payne while still an industry guy is well up there in age and there isn't an hier apparent to the ZIVO throne with the exception of Cornell who I think has the skillset to handle it ..... but Payne is the guy and it's his baby at this point. ZIVO has a shitload of loss carryforwards that have value as well ..... so gimme $25-$40 and lets move on already. Too cheap but ZIVO can't prove all the vertical options in a reasonable time and doesn't have the coin to do it ..... so it's time to get something done. That would be pocket change to a big boy animal pharma.
Amigo Mike
Looking like more sellers lined up at the ask at $8 ......
Including one for 6666 ... funny .... likely a retailer via ETRF. Stupid but just MO. Would take months to clear that based on the current volume but anticipate the seller knows that. Of course if there is positive ZIVO news ..... the could be taken out in a flash and be left in the dust.
Oh well .....
Amigo Mike
I certainly agree on the clownshow.
Been that way for a long time.
I do think Payne knows the game being the pharma insider that he is ..... but ...... he's on the other side of the fence at this point. And while not CEO that whole time has been a director of the company for several years ..... so ...... it's past time.
We will see one way or another.
Amigo Mike
LOL,
This is another error on mgmt's part IMHO. I'm pretty sure investors temperature's are running hot right now what with the lack of anything from mgmt and no call in to the meeting is likely one more for the top of the pile.
I would anticipate there will be an 8K filed that provides the CEO letter and the results of the elections which of course for this go round isn't much. Masterson on the ballot ...... that is a withhold at best in lieu of not having option for "AGAINST" flat out.
I won't speculate on the meeting ... but I think it is ALWAYS a mistake not to engage investors ... good or bad. No action in the stock today so if anyone was in attendance, nobody ran out to "buy" or "sell" based on what they heard. =) I know the last shareholders meeting I was at, I knew the stock was a sell coming out of it.
It's time for this company to take the next step .... whatever that step may be.
Amigo Mike
Soooooooooooooo,
Did I miss the PR with the call in information for the shareholder meeting today ??
Amigo Mike